影响内镜下经蝶窦手术治疗垂体腺瘤患者视觉结局的因素
研究纳入47例接受内镜下经蝶窦手术(ETS)的垂体腺瘤(PA)患者,定量评估手术前后视力(VA)与视野(VF)。结果显示VA在76眼中54眼(71.0%)改善,69眼(90.7%)恢复至正常;VF在37眼中32眼(86.5%)恢复。术前视觉障碍评分(VISpre)大于40时视觉结局较差;当VISpre为21-40时,年龄与VIS改善线性相关(P=0.03)。鞍上扩展(SSE)是ETS术后视觉结局最重要的预测因素。
要点
- ETS术后71.0%的眼(54/76)视力改善,90.7%(69/76)恢复至正常视力。
- 术前VISpre大于40者术后视觉结局较差;VISpre为21-40时年龄与VIS改善线性相关(P=0.03)。
- 鞍上扩展(SSE)是ETS术后视觉结局最重要的预测因素,视觉障碍的SSE截断值为9.5 mm。
核心结论
- ETS治疗PA的视觉结局优良,严重并发症罕见。
- 严重的术前视觉障碍导致较差的术后视觉结局。
- PA的鞍上扩展(SSE)是ETS术后视觉结局最重要的预测因素。
研究设计与样本
- 评估47例接受ETS的PA患者的医疗记录,定量测定VA、VF、术前VISpre和术后VISpost,并评估PA的SSE、体积、视交叉接触与视觉功能的相关性。
主要发现
- ETS术后VA在76眼中54眼(71.0%)改善,69眼(90.7%)获得正常VA。
- 术后VF恢复发生在37眼中32眼(86.5%)。
- VIS平均变化为12.0(95%CI 7.7-16.3),在所有肿瘤相关视觉障碍患者(n=25)中均改善。
- VISpre大于40时视觉结局较差;VISpre为21-40时,年龄与VIS改善线性相关(P=0.03),年轻患者结局满意而年长患者较差。
- 有VF缺陷患者(n=20)的平均SSE为16.6 mm(95%CI 13.3-19.9),无VF缺陷患者(n=23)的平均SSE为6.6 mm(95%CI 4.9-8.3;P<0.001),视觉障碍的截断值为SSE 9.5 mm和PA体积8.6 mL(两者P<0.001)。
关键数值与推荐
- 术前VISpre大于40提示术后视觉结局较差。
- 当VISpre为21-40时,年龄与VIS改善线性相关(P=0.03)。
- 视觉障碍的SSE截断值为9.5 mm,PA体积截断值为8.6 mL(两者P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate visual acuity (VA) and visual fields (VF) quantitatively before and after endoscopic transsphenoidal surgery (ETS), with special attention to prognostic factors such as the pituitary adenoma (PA) suprasellar extension (SSE), volume and the patients' age. METHODS: Medical records of 47 patients with PA undergoing ETS were evaluated. VA, VF, preoperative visual impairment score (VISpre) and postoperative visual impairment score (VISpost) were determined. The PA SSE, volume, chiasmal contact, and their correlation with visual function were assessed preoperatively and postoperatively. RESULTS: The final cohort included 47 patients. VA improved in 54 of 76 eyes (71.0%) after ETS, and 69 of 76 eyes (90.7%) gained normal VA. Postoperative VF recovery occurred in 32 of 37 eyes (86.5%). The mean change in VIS was 12.0 (95% confidence interval [CI], 7.7-16.3) and improved in all patients with tumor-related visual impairment (n = 25). However, visual outcome was poorer when VISpre was greater than 40. When VISpre was 21-40, age linearly correlated with VIS improvement (P = 0.03); younger patients had satisfactory and older poorer visual outcome. The mean SSE in patients with VF defects (n = 20) was 16.6 mm (95% CI, 13.3-19.9). Mean SSE in patients with no VF defects (n = 23) was 6.6 mm (95% CI, 4.9-8.3; P < 0.001), and the cutoff value for visual perturbations was 9.5 mm for SSE and 8.6 mL for PA volume (P < 0.001 for both). CONCLUSIONS: The visual outcome after ETS for PAs was excellent, and serious complications were rare. Severe preoperative visual impairment resulted in poorer postoperative visual outcomes. The SSE of the PA was the most important predictor of visual outcome after ETS.
引用
- Luomaranta T, Raappana A, Saarela V, et al. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated with Endoscopic Transsphenoidal Surgery. World Neurosurg. 2017. PMID: 28583452. doi:10.1016/j.wneu.2017.05.144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。